$25.44
-0.06 (-0.24%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+184.2% upside
Low Target
$45.76
Average Target
$72.29
High Target
$82.91
Current Price
$25.44
Current
$25.44
$25.44
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Scenario Analysis
Bear Case
$45.76
79.9%
Low target
Base Case
$72.29
+184.2%
Avg target
Bull Case
$82.91
+225.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$28.23
-9.9% from high
52-Week Low
$8.20
+210.4% from low
Target vs 52W High
$72.29
+156.1% vs high
Next Earnings Report
Oct 7, 2026
13d
until earnings
EPS Est: $-0.61
Earnings in 13 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |